Patents Assigned to Lysulin, Inc.
  • Levels, functions, and resistances related to chronic conditions by using lysine-based supplements
    Patent number: 11255838
    Abstract: Systems and method that relate to improving levels, functions, and resistances related to chronic conditions by using lysine-based supplements are described. For example, a method of monitoring an analyte level may include administering a supplement that may include lysine, zinc, and vitamin C to a user. The method may also include monitoring an analyte level in a bio-sample before and after the supplement is administered.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: February 22, 2022
    Assignee: LYSULIN, INC.
    Inventor: John Burd
  • Method of improving beta cell function using a supplement
    Patent number: 11045495
    Abstract: A method of improving beta cell function by using a supplement, the comprising: administering the supplement comprising lysine, zinc, and vitamin C to a user; monitoring an insulin resistance level before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the insulin resistance level found in the bio-sample.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: June 29, 2021
    Assignee: Lysulin, Inc.
    Inventor: John Burd
  • Prevention of protein glycation using lysine supplements
    Patent number: 10980834
    Abstract: A method of preventing protein glycation using a supplement may comprise: administering a supplement comprising lysine and zinc; monitoring a concentration of glucose before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the concentration of glucose found in the bio-sample.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: April 20, 2021
    Assignee: Lysulin, Inc.
    Inventor: John Burd
  • Prevention of protein glycation using lysine supplements
    Patent number: 10695368
    Abstract: A method of preventing protein glycation using a supplement may comprise: administering a supplement comprising lysine and zinc; monitoring a concentration of glucose before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the concentration of glucose found in the bio-sample.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: June 30, 2020
    Assignee: Lysulin, Inc.
    Inventor: John Burd
  • Inhibiting chronic blood and nephrological disorders using lysine-based supplements
    Patent number: 10656166
    Abstract: A method of affecting blood chemistry using a supplement may comprise: measuring a blood glucose level; determining a blood glucose level; and if the blood glucose level exceeds a threshold, administering a supplement comprising lysine, zinc, and vitamin C.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: May 19, 2020
    Assignee: Lysulin, Inc.
    Inventor: John Burd
  • Prevention of protein glycation using lysine/zinc supplements
    Patent number: 10653720
    Abstract: A method of preventing protein glycation using a supplement may comprise: administering a supplement comprising lysine and zinc; monitoring a concentration of glucose before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the concentration of glucose found in the bio-sample.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: May 19, 2020
    Assignee: Lysulin, Inc.
    Inventor: John Burd
  • Insulin resistance and beta cell function using lysine-based supplements
    Patent number: 10610544
    Abstract: A method of improving insulin resistance by using a supplement may include: administering the supplement including lysine, zinc, and vitamin C to a user; monitoring an insulin resistance level before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the insulin resistance level found in the bio-sample.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: April 7, 2020
    Assignee: Lysulin, Inc.
    Inventor: John Burd
  • Inhibiting chronic blood and nephrological disorders using lysine-based supplements
    Patent number: 10466256
    Abstract: A method of determining a stage of CKD may comprise: measuring a creatinine level; determining a creatinine level; determining a glomerular filtration rate; and determining a stage of CKD.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: November 5, 2019
    Assignee: Lysulin, Inc.
    Inventor: John Burd